PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In a recent prospective study, for example, PNPLA3 and TM6SF2 variants genotyping allowed for the improvement of risk stratification, thereby ameliorating the prediction of NAFLD development in obese adolescents, especially in those born with intrauterine growth retardation favoring insulin resistance [82].